Paolo Santambrogio Selected Research

Paolo Santambrogio Research Topics

Disease

5	Movement Disorders (Movement Disorder) 04/2021 - 09/2006
5	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 12/2020 - 09/2012
4	Neuroferritinopathy 04/2021 - 09/2006
4	Friedreich Ataxia (Friedreich's Ataxia) 12/2012 - 10/2004
3	Iron Overload 01/2022 - 10/2004
3	Mitochondrial Diseases (Mitochondrial Disease) 12/2020 - 09/2015
3	Starvation 12/2020 - 10/2011
3	Hypoxia (Hypoxemia) 10/2019 - 08/2005
3	Parkinson Disease (Parkinson's Disease) 05/2007 - 06/2004
2	Infections 12/2021 - 01/2013
2	Neurodegeneration with brain iron accumulation (NBIA) 04/2021 - 01/2019
2	Neoplasms (Cancer) 12/2020 - 08/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2016 - 09/2012
2	Hypertrophy 01/2015 - 12/2012
2	Cardiomyopathies (Cardiomyopathy) 01/2015 - 12/2012
2	Sideroblastic Anemia 10/2011 - 10/2004
2	Inflammation (Inflammations) 03/2010 - 03/2009
2	Altitude Sickness (Mountain Sickness) 06/2009 - 06/2007
1	Granuloma 12/2021
1	Dystonia (Limb Dystonia) 12/2020
1	Cognitive Dysfunction 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Hyperferritinemia 04/2017
1	Ovarian Cysts (Ovarian Cyst) 03/2014
1	Endometriosis 03/2014
1	Iron Deficiencies 12/2013
1	Restless Legs Syndrome (Restless Legs) 08/2013
1	Seizures (Absence Seizure) 08/2013
1	Multiple Myeloma 06/2013
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2013
1	Cicatrix (Scar) 12/2012
1	Necrosis 12/2012
1	Macular Degeneration (Age-Related Maculopathy) 01/2012
1	Refractory Anemia 10/2011
1	Anemia 01/2007
1	Kidney Neoplasms (Kidney Cancer) 08/2005
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2005
1	Hemochromatosis (Bronze Diabetes) 12/2004
1	Cardiotoxicity 04/2004
1	Gliosis 07/2002

Drug/Important Bio-Agent (IBA)

32	IronIBA 12/2021 - 04/2004
12	Ferritins (Ferritin)IBA 04/2021 - 01/2007
11	ApoferritinsIBA 12/2021 - 09/2006
8	Proteins (Proteins, Gene)FDA Link 12/2020 - 06/2007
4	FrataxinIBA 01/2015 - 10/2004
3	Coenzyme A (CoA)IBA 01/2022 - 09/2015
2	metal transporting protein 1 (ferroportin)IBA 12/2021 - 12/2004
2	CalciumIBA 12/2020 - 05/2020
2	Oxygen (Dioxygen)IBA 10/2019 - 06/2007
2	EnzymesIBA 09/2015 - 01/2009
2	MetalsIBA 01/2015 - 06/2004
2	Transferrin Receptors (Transferrin Receptor)IBA 03/2014 - 08/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2011 - 04/2004
2	NucleotidesIBA 04/2010 - 09/2006
2	MyoglobinIBA 06/2009 - 06/2007
1	CytokinesIBA 12/2021
1	MagnesiumIBA 12/2020
1	AndrogensIBA 12/2020
1	Androgen Antagonists (Antiandrogens)IBA 12/2020
1	bicalutamide (Casodex)FDA LinkGeneric 12/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015
1	ZincIBA 01/2015
1	HepcidinsIBA 01/2015
1	Anti-Mullerian HormoneIBA 03/2014
1	Messenger RNA (mRNA)IBA 03/2014
1	Pharmaceutical PreparationsIBA 06/2013
1	Small Interfering RNA (siRNA)IBA 06/2013
1	Bortezomib (Velcade)FDA Link 06/2013
1	Toll-Like Receptor 2IBA 01/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2012
1	Retinaldehyde (Retinal)IBA 01/2012
1	Hemoglobins (Hemoglobin)IBA 06/2007
1	Peptides (Polypeptides)IBA 09/2006
1	Transferrin (beta 2 Transferrin)IBA 08/2005
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 10/2004
1	Mitochondrial DNA (mtDNA)IBA 10/2004
1	NoxaeIBA 06/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2004
1	AnthracyclinesIBA 04/2004
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 07/2002

Therapy/Procedure

3	Therapeutics 12/2020 - 01/2015